Evidence map›Paper›PMID 24348205›Full record

ArticleJournal of chemical theory and computation2012

HIV-1 Protease and Substrate Coevolution Validates the Substrate Envelope As the Substrate Recognition Pattern.

Ayşegül Ozen, Türkan Haliloğlu, Celia A Schiffer

Open access · greenAbstract read
In one paragraph

Article in Journal of chemical theory and computation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Acta pharmaceutica Sinica. B · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Interdependence of Inhibitor Recognition in HIV-1 Protease.Journal of chemical theory and computation · 2017
    Article
  9. Article
  10. Article
  11. Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ayşegül OzenDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States.
Türkan HaliloğluPolymer Research Center, Bogazici University, Bebek, Istanbul, Turkey.
Celia A SchifferDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States.
University of Massachusetts Chan Medical School · USBoğaziçi University · TR

Funding

Targeting ensembles of Drug Resistant HIV ProteasesP01GM066524 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RANA, TARIQ M · 2002 to 2011
$16.3M
Targeting Drug Resistance in HIV-1 ProteaseR01GM064347 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHIFFER, CELIA A. · 2001 to 2013
$4.5M
NIGMS NIH HHS P01 GM066524NIGMS NIH HHS R01 GM064347
6 · The paper itself

Abstract

Drug resistance of HIV-1 protease alters the balance in the molecular recognition events in favor of substrate processing versus inhibitor binding. To develop robust inhibitors targeting ensembles of drug-resistant variants, the code of this balance needs to be cracked. For this purpose, the principles governing the substrate recognition are required to be revealed. Previous crystallographic studies on the WT protease-substrate complexes showed that the substrates have a conserved consensus volume in the protease active site despite their low sequence homology. This consensus volume is termed as the substrate envelope. The substrate envelope was recently reevaluated by taking the substrate dynamics into account, and the dynamic substrate envelope was reported to better define the substrate specificity for HIV-1 protease. Drug resistance occurs mostly through mutations in the protease, occasionally accompanied by cleavage site mutations. In this study, three coevolved protease-substrate complexes (

Identifiers

PMID24348205
PMCPMC3862175
OpenAlexW2066838105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.